Tidmarsh, MD, PhD, is to oversee the safety and effectiveness of over-the-counter and prescription drugs at the CDER.

The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...

The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time ...

Gilead Sciences (GILD) stock gains as Needham upgrades the company to Buy from Hold citing its new HIV prevention injectable, ...